z-logo
open-access-imgOpen Access
Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients
Author(s) -
Luhong Wang,
Yinan Ding,
Chuanyong Zhang,
Rong Chen
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269249
Subject(s) - kegg , druggability , drug repositioning , transcriptome , gene , hepatocellular carcinoma , interaction network , biology , gene ontology , computational biology , transcription factor , coronavirus , bioinformatics , disease , genetics , covid-19 , medicine , gene expression , drug , infectious disease (medical specialty) , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom